z-logo
open-access-imgOpen Access
CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
Author(s) -
Yalan Bi,
Xiaohua Shi,
Dian Chen,
Yi Zhao
Publication year - 2022
Publication title -
clinical cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s373331
Subject(s) - receiver operating characteristic , biomarker , cd44 , medicine , area under the curve , immunostaining , gastroenterology , pathology , basal cell carcinoma , basal (medicine) , immunohistochemistry , basal cell , cell , biology , biochemistry , genetics , insulin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom